BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Job Trends

  Qiagen Plans to Create Up to 800 Jobs at New UK Campus Post Brexit

  Qiagen’s investment will be an expansion of its current operations in that northern England city.

  November 27, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Teva Shakes Up C-Suite in Restructuring

  Since taking over at Teva earlier this fall, Kare Schultz has been swiftly moving to shore up the finances and pay down the massive debts of the beleaguered pharmaceutical company.

  November 27, 2017

   · 

  2 min read

   · 

  Alex Keown
• Immunochina Lands $7.5M for CAR-T Drug Trials

  Immunochina raised $7.5M to support clinical trials of its CAR-T product for lymphoma.

  November 27, 2017

   · 

  1 min read
• 3D Medicines Raises $101M for Cancer Diagnostics and Drugs

  The funding was led by China Reform Holdings and joined by ChinaEquity Group and several unnamed investors.

  November 27, 2017

   · 

  1 min read
• 

  Business

  Boehringer Focuses on RNA

  Boehringer has made a big push into RNA this month.

  November 27, 2017

   · 

  1 min read

   · 

  Karl Thiel
• 

  Policy

  Stem Cells Ready for Prime Time?

  A look at the FDA’s long-awaited guidelines on how it will regulate regenerative medicine products, including stem cells.

  November 27, 2017

   · 

  1 min read

   · 

  Karl Thiel
• 

  Biotech Bay

  Are We Reaching the Biotech Singularity?

  The “singularity” is a term favored by futurists like Google exec Ray Kurzweill, typically in reference to computer technology.

  November 27, 2017

   · 

  4 min read

   · 

  Karl Thiel
• 

  Business

  Teva Expected to Fire Up to 1,700 Workers in Israel, U.S.

  News of the layoffs comes hard on the heels of the company’s credit rating having been cut to junk status by Fitch Rating.

  November 27, 2017

   · 

  2 min read

   · 

  Alex Keown
• Business

  Lee’s Pharm Forms Second China Cancer Partnership With Beijing Shenogen

  In the latest joint effort, Lee’s Pharm will pair its PD-L1 candidate with icaritin.

  November 27, 2017

   · 

  1 min read
• Eisai to Present Latest Data on Perampanel and Rufinamide at 71st American Epilepsy Society Annual Meeting

  Inovelon will be presented at the 71st AES Annual Meeting to be held from December 1 to 5, 2017 in Washington D.C. in the United States.

  November 27, 2017

   · 

  2 min read